price
NASDAQ · PFE
Pfizer Inc.
Healthcare · Drug Manufacturers - General
$27.55
Down-$0.08 (-0.28%)
Updated Sep 16, 2026, 2:55 PM
SID Score
7.1/10
Composite research score
Smart Money
71/100
Bullish
- Market cap
- 146.75B
- P/E ratio
- 14.94
- Dividend yield
- 6.24%
- 52-week range
- $23.62 – $29.21
- Volume
- 40.44M
- Avg. volume
- 68.83M
Price performance
PFE price history
1M range · 20 trading sessions · Daily adjusted prices
PFE closed at $27.55 after 20 trading sessions, up 1.10% for the selected period.
- Last close
- $27.55
- Period change
- +1.10%
- Period low
- $27.25
- Period high
- $29.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $27.615 | $27.66 | $27.245 | $27.55 | 40.44M |
| Sep 14, 2026 | $28.08 | $28.19 | $27.685 | $27.72 | 28.57M |
| Sep 11, 2026 | $27.80 | $27.85 | $27.42 | $27.72 | 25.56M |
| Sep 10, 2026 | $27.69 | $27.75 | $27.40 | $27.65 | 28.81M |
| Sep 9, 2026 | $27.76 | $27.975 | $27.57 | $27.78 | 29.14M |
| Sep 8, 2026 | $28.015 | $28.145 | $27.715 | $27.79 | 31.77M |
| Sep 4, 2026 | $28.58 | $28.69 | $28.38 | $28.45 | 23.79M |
| Sep 3, 2026 | $29.09 | $29.21 | $28.44 | $28.81 | 26.72M |
| Sep 2, 2026 | $28.79 | $29.09 | $28.705 | $29.02 | 39.28M |
| Sep 1, 2026 | $28.818 | $29.09 | $28.465 | $28.55 | 42.49M |
| Aug 31, 2026 | $27.85 | $28.70 | $27.64 | $28.46 | 45.93M |
| Aug 28, 2026 | $28.00 | $28.02 | $27.77 | $27.96 | 27.18M |
| Aug 27, 2026 | $27.97 | $28.18 | $27.83 | $28.02 | 31.17M |
| Aug 26, 2026 | $28.44 | $28.50 | $28.145 | $28.30 | 35.07M |
| Aug 25, 2026 | $27.915 | $28.58 | $27.84 | $28.57 | 31.92M |
| Aug 24, 2026 | $28.10 | $28.1561 | $27.81 | $27.97 | 23.85M |
| Aug 21, 2026 | $27.77 | $28.425 | $27.655 | $28.07 | 37.11M |
| Aug 20, 2026 | $28.00 | $28.16 | $27.645 | $27.79 | 29.3M |
| Aug 19, 2026 | $27.60 | $28.435 | $27.58 | $28.24 | 59.8M |
| Aug 18, 2026 | $27.15 | $27.395 | $27.10 | $27.25 | 34.66M |
Latest PFE news
The latest Smart Investors Daily articles mentioning PFE.
Stock researchResearch & News · Competitors
Loading stock research…